Evidence map›Paper›PMID 30813401›Full record

ReviewInternational journal of molecular sciences2019

Role of p90RSK in Kidney and Other Diseases.

Ling Lin, Samantha A White, Kebin Hu

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. p90RSK modulates inter-and intracellular signaling in kidney diseases.Frontiers in cell and developmental biology · 2025
    Review
  6. Epigenome-wide Association Study for Tic Disorders in Children: A Preliminary Study in Korean Population.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2024
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Rhein inhibitsFrontiers in public health · 2022
    Article
  15. Article
  16. Article
  17. The Roles of Post-Translational Modifications on mTOR Signaling.International journal of molecular sciences · 2021
    Review
  18. Oxidative Stress Orchestrates MAPK and Nitric-Oxide Synthase Signal.International journal of molecular sciences · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ling LinDepartment of Cellular and Molecular Physiology, The Pennsylvania State University College of Medicine, 500 University Drive, Hershey, PA 17033, USA. llin1@pennstatehealth.psu.edu.
Samantha A WhiteDepartment of Cellular and Molecular Physiology, The Pennsylvania State University College of Medicine, 500 University Drive, Hershey, PA 17033, USA. swhite11@pennstatehealth.psu.edu.ORCID 0000-0001-9619-4847
Kebin HuDepartment of Cellular and Molecular Physiology, The Pennsylvania State University College of Medicine, 500 University Drive, Hershey, PA 17033, USA. kebinhu@pennstatehealth.psu.edu.ORCID 0000-0002-0829-4256
Pennsylvania State University · US

Funding

p90 Ribosomal S6 Kinase and Chronic Kidney DiseaseR01DK102624 · NIDDK · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI HU, KEBIN · 2014 to 2018
$1.5M
American Heart Association 14GRNT20380289National Institute of Diabetes and Digestive and Kidney Diseases 1R01DK102624NIDDK NIH HHS R01 DK102624
6 · The paper itself

Abstract

The 90 kDa ribosomal s6 kinases (RSKs) are a group of serine/threonine kinases consisting of 4 RSK isoforms (RSK1-4), of which RSK1 is also designated as p90RSK. p90RSK plays an important role in the Ras-mitogen-activated protein kinase (MAPK) signalling cascade and is the direct downstream effector of Ras-extracellular signal-regulated kinase (ERK1/2) signalling. ERK1/2 activation directly phosphorylates and activates p90RSK, which, in turn, activates various signalling events through selection of different phosphorylation substrates. Upregulation of p90RSK has been reported in numerous human diseases. p90RSK plays an important role in the regulation of diverse cellular processes. Thus, aberrant activation of p90RSK plays a critical role in the pathogenesis of organ dysfunction and damage. In this review, we focus on the current understanding of p90RSK functions and roles in the development and progression of kidney diseases. Roles of p90RSK, as well as other RSKs, in cardiovascular disorders and cancers are also discussed.

Indexed as

AnimalsCardiovascular DiseasesHumansKidneyKidney DiseasesNeoplasmsRibosomal Protein S6 Kinases, 90-kDaSignal TransductionRibosomal Protein S6 Kinases, 90-kDaatherosclerosiskidneykinase inhibitorsp90RSKpathophysiologysignalling

Identifiers

PMID30813401
PMCPMC6412535
OpenAlexW2917909413

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.